Icen-Taskin Irmak, Irtegun-Kandemir Sevgi, Munzuroglu Omer
Department of Molecular Biology and Genetics, Faculty of Science and Art, Inonu University, Malatya, Turkey.
Department of Medical Biology, Faculty of Medicine, Dicle University, Diyarbakir, Turkey.
J Res Med Sci. 2020 Mar 18;25:25. doi: 10.4103/jrms.JRMS_506_19. eCollection 2020.
Breast cancer is the leading cause of cancer deaths among women. Early-onset breast cancer is well recognized as it clinically differs from old-age diagnosed breast neoplasms. polymorphism relates to the risk of breast neoplasms, but this relationship in Turkish early-onset breast cancer patients has not been investigated yet. We aimed to search the relationship between polymorphism and young Turkish breast cancer patients.
Ninety-six female breast cancer patients who were ≤ 40 years of age and 96 healthy controls were enrolled in our study. Participants were genotyped by the hybridization probe system.
We identified that the genotype frequencies of were significantly different between controls and cases ( = 0.027). Participants carrying CG genotype had also reduced breast cancer risk (odds ratio = 0.4196, 95% confidence interval: 0.1941-0.9067, = 0.027). Our results revealed that there is an association between GG and CG + CC genotype groups with progesterone receptor (PgR) status ( = 0.0219).
Our findings indicate that the CG genotype is a protective factor against breast neoplasms. No other clinicopathologic parameters except for PgR status were found to be related to polymorphism in young Turkish breast cancer patients.
乳腺癌是女性癌症死亡的主要原因。早发性乳腺癌已得到充分认识,因为其在临床上与老年诊断出的乳腺肿瘤不同。[基因]多态性与乳腺肿瘤风险相关,但土耳其早发性乳腺癌患者中的这种关系尚未得到研究。我们旨在探究[基因]多态性与年轻土耳其乳腺癌患者之间的关系。
96名年龄≤40岁的女性乳腺癌患者和96名健康对照者纳入我们的研究。参与者通过杂交探针系统进行基因分型。
我们发现,[基因]的基因型频率在对照组和病例组之间存在显著差异(P = 0.027)。携带CG基因型的参与者患乳腺癌的风险也降低(优势比= 0.4196,95%置信区间:0.1941 - 0.9067,P = 0.027)。我们的结果显示,GG和CG + CC基因型组与孕激素受体(PgR)状态之间存在关联(P = 0.0219)。
我们的研究结果表明,CG基因型是预防乳腺肿瘤的一个保护因素。在年轻土耳其乳腺癌患者中,除了PgR状态外,未发现其他临床病理参数与[基因]多态性相关。